Lumakras, manufactured by Amgen Inc. and marketed under the brand name Blincyto, represents a remarkable advancement in the field of oncology, particularly for patients grappling with Non-Small Cell Lung Cancer (NSCLC). Powered by the active ingredient Sotorasib, Lumakras embodies a commitment to innovation and scientific progress, redefining the landscape of NSCLC treatment with its precision-focused […]
